{"product_id":"innobruka-orelabrutinib","title":"INNOBRUKA (Orelabrutinib)","description":"\u003cp\u003eOrelabrutinib is a novel, highly selective, irreversible BTK inhibitor with high target selectivity and safety. \u003c\/p\u003e\u003cul\u003e\u003cli\u003e\n\u003cspan data-huuid=\"5813577302449632437\"\u003eOrelabrutinib \u003c\/span\u003esold under the brand name 宜诺凯（INNOBRUKA）® in china.\u003c\/li\u003e\u003c\/ul\u003e\u003cp\u003eIn China, it is approved for patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL), who have received at least one treatment in the past.\u003csup id=\"cite_ref-1\" class=\"reference\"\u003e\u003c\/sup\u003e\u003c\/p\u003e","brand":"InnoCare Pharma, China","offers":[{"title":"Default Title","offer_id":44797956784171,"sku":"RL3220250101","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/2025-01-0745.png?v=1787022269","url":"https:\/\/xomeds.com\/products\/innobruka-orelabrutinib","provider":"XOMEDS","version":"1.0","type":"link"}